Children’s Healthcare of Atlanta was recently selected as an OUtMATCH clinical trial site to test whether omalizumab, an FDA-approved treatment for asthma, could be effective at protecting patients with multiple food allergies.
A Children’s Healthcare of Atlanta patient has become the youngest patient to date to receive experimental convalescent plasma transfusions to treat the novel coronavirus.
IDG’s Insider Pro and Computerworld recognize Children’s in 2020 rankings
Clinical Trial Opens to Place Stem Cells Into Hearts Collaborative trail one of three stem cell clinical trials for HLHS in the country Friday, Feb. 28, 2020 Collaborative trail one of three stem...
Imlay Innovation Research Grants for 2020 were awarded by the Children’s Healthcare of Atlanta Pediatric Technology Center to Georgia Tech engineers for orthopedics and pulmonology projects.
Dr. Frank Named 2019 Paul V. Miles Fellow Gary Frank, MD, MS, selected to receive 2019 Paul V. Miles Fellowship Award Tuesday, Jan. 22, 2019 Gary Frank, MD, MS, selected to receive 2019 Paul V. Miles...
Read more about the study here.
Mutation in Bone Cells May Cause Leukemia Research finds that certain DNA mutations in bone cells can drive leukemia formation in nearby blood stem Wednesday, Oct. 26, 2016 Research finds that...
A new study published today in the New England Journal of Medicine could lead to therapeutic treatment options for children and adolescents allergic to peanuts.
Crafting a Vaccine Against RSV Scientists believe they have found a way to craft an RSV vaccine Thursday, Dec. 22, 2016 Scientists believe they have found a way to craft an RSV vaccine Thursday, Dec....